科研成果详情

题名Implication of serum soluble IL-2 receptor α in type 2 diabetes mellitus
作者
发表日期2024-12-20
发表期刊JOURNAL OF DIABETES AND METABOLIC DISORDERS   影响因子和分区
语种英语
原始文献类型Article
关键词Type 2 diabetes mellitus Diabetic kidney disease IL-2 receptor
其他关键词KIDNEY-DISEASE ; DIAGNOSIS ; INTERLEUKIN-2-RECEPTOR ; ADIPOGENESIS ; PROGRESSION ; GAMMA ; CELLS
摘要ObjectivesThe aim of this study was to determine the association of serum soluble IL-2 receptor alpha (sIL-2RA) with T2DM-related characteristics and complications. MethodsSerum sIL-2RA levels were determined in 156 T2DM patients, and the association with T2DM-related characteristics and complications was evaluated. ResultsSerum sIL-2RA levels were significantly increased in T2DM patients with diabetic kidney disease (DKD) (median, IQR, 1434.9, 958.1-1896.0, pg/ml), in comparison with those without DKD (median, IQR, 851.2, 660.2-1089.9, pg/ml)(P < 0.001). The ROC analysis revealed good performance of sIL-2RA for identifying DKD, with the areas under the curve of 0.789 (95%CI of 0.711-0.867, P < 0.001). The correlation analyses showed significantly positive correlations of serum sIL-2RA with urea (r = 0.458, P < 0.001), creatinine (r = 0.508, P < 0.001) and uACR (r = 0.469, P < 0.001), and negative correlation with eGFR (r=-0.561, P < 0.001). The multivariate analyses showed that serum sIL-2RA was independently associated with the increased risks of DKD (OR, 95%CI, 6.539, 1.401-30.529, P = 0.017) and DR (OR, 95%CI, 3.606, 1.073-12.114, P = 0.038). Additionally, serum sIL-2RA was significantly associated with inflammatory indicators in DKD patients, and with metablic indicators in non-DKD patients (all P < 0.05). ConclusionSerum sIL-2RA may be closely associated with inflammation, glucose and lipid metabolisms, DKD and DR risks in T2DM. Furthermore, it may be a potential biomarker for T2DM-related micro-vascular complications.
资助项目Medical Health Science and Technology Project of Zhejiang Provincial Health Commission [2024KY532]; Taizhou Science and Technology Project [22ywa31]
出版者SPRINGER INT PUBL AG
ISSN2251-6581
EISSN2251-6581
卷号24期号:1
DOI10.1007/s40200-024-01536-x
页数10
WOS类目Endocrinology & Metabolism
WOS研究方向Endocrinology & Metabolism
WOS记录号WOS:001381132600006
收录类别ESCI ; SCOPUS ; PUBMED
URL查看原文
PubMed ID39712341
SCOPUSEID2-s2.0-85212697468
通讯作者地址[Li, Jie;Yang, Zaixing]Wenzhou Med Univ, Taizhou Peoples Hosp 1, Huangyan Hosp, Dept Lab Med, Taizhou, Peoples R China.
Scopus学科分类Internal Medicine;Endocrinology, Diabetes and Metabolism
SCOPUS_IDSCOPUS_ID:85212697468
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/224880
专题其他_附属黄岩医院(台州市第一人民医院)
通讯作者Li, Jie; Yang, Zaixing
作者单位
1.Wenzhou Med Univ, Taizhou Peoples Hosp 1, Huangyan Hosp, Dept Lab Med, Taizhou, Peoples R China;
2.Fujian Med Univ, Mengchao Hepatobiliary Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China;
3.Xuzhou Med Univ, Peoples Hosp Changshu 2, Dept Sci & Technol, Key Lab,Affiliated Changshu Hosp, Changshu, Jiangshu, Peoples R China;
4.Wenzhou Med Univ, Taizhou Peoples Hosp 1, Dept Oncol, Huangyan Hosp, Taizhou, Peoples R China
第一作者单位其他_附属黄岩医院(台州市第一人民医院)
通讯作者单位其他_附属黄岩医院(台州市第一人民医院)
第一作者的第一单位其他_附属黄岩医院(台州市第一人民医院)
推荐引用方式
GB/T 7714
Zhao, Bing,Zhang, Miaomiao,Liao, Shaoguang,et al. Implication of serum soluble IL-2 receptor α in type 2 diabetes mellitus[J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS,2024,24(1).
APA Zhao, Bing, Zhang, Miaomiao, Liao, Shaoguang, Jiang, Tingwang, Li, Jie, & Yang, Zaixing. (2024). Implication of serum soluble IL-2 receptor α in type 2 diabetes mellitus. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 24(1).
MLA Zhao, Bing,et al."Implication of serum soluble IL-2 receptor α in type 2 diabetes mellitus".JOURNAL OF DIABETES AND METABOLIC DISORDERS 24.1(2024).

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Zhao, Bing]的文章
[Zhang, Miaomiao]的文章
[Liao, Shaoguang]的文章
百度学术
百度学术中相似的文章
[Zhao, Bing]的文章
[Zhang, Miaomiao]的文章
[Liao, Shaoguang]的文章
必应学术
必应学术中相似的文章
[Zhao, Bing]的文章
[Zhang, Miaomiao]的文章
[Liao, Shaoguang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。